JAZZ

Jazz Pharmaceuticals plc

Healthcare›Biotechnology|NASDAQ Global Select|IE

Price

$186.95

Market Cap

$11.51B

Beta

0.23

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+4.88%

EPS Growth (YoY)-100.00%

Revenue CAGR 3Y+5.26%

P/E Ratio0.0

PEG Ratio—

FCF Yield+10.84%

Debt / Equity1.25

Interest Coverage1.2x

No credit card required

Already have an account? Sign in to view the full analysis for JAZZ.